These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21932860)

  • 1. RASA: a rapid retrosynthesis-based scoring method for the assessment of synthetic accessibility of drug-like molecules.
    Huang Q; Li LL; Yang SY
    J Chem Inf Model; 2011 Oct; 51(10):2768-77. PubMed ID: 21932860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SYNOPSIS: SYNthesize and OPtimize System in Silico.
    Vinkers HM; de Jonge MR; Daeyaert FF; Heeres J; Koymans LM; van Lenthe JH; Lewi PJ; Timmerman H; Van Aken K; Janssen PA
    J Med Chem; 2003 Jun; 46(13):2765-73. PubMed ID: 12801239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition.
    Takaoka Y; Endo Y; Yamanobe S; Kakinuma H; Okubo T; Shimazaki Y; Ota T; Sumiya S; Yoshikawa K
    J Chem Inf Comput Sci; 2003; 43(4):1269-75. PubMed ID: 12870920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic approaches to the 2010 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Flick AC; Ding HX
    Bioorg Med Chem; 2012 Feb; 20(3):1155-74. PubMed ID: 22261026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and reaction based evaluation of synthetic accessibility.
    Boda K; Seidel T; Gasteiger J
    J Comput Aided Mol Des; 2007 Jun; 21(6):311-25. PubMed ID: 17294248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated medicinal chemistry.
    Koppitz M; Eis K
    Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical assessment of synthetic accessibility scores in computer-assisted synthesis planning.
    Skoraczyński G; Kitlas M; Miasojedow B; Gambin A
    J Cheminform; 2023 Jan; 15(1):6. PubMed ID: 36641473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of structural diversity in combinatorial synthesis.
    Fergus S; Bender A; Spring DR
    Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PhDD: a new pharmacophore-based de novo design method of drug-like molecules combined with assessment of synthetic accessibility.
    Huang Q; Li LL; Yang SY
    J Mol Graph Model; 2010 Jun; 28(8):775-87. PubMed ID: 20206562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing synthetic accessibility of chemical compounds using machine learning methods.
    Podolyan Y; Walters MA; Karypis G
    J Chem Inf Model; 2010 Jun; 50(6):979-91. PubMed ID: 20536191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-H activation reactions as useful tools for medicinal chemists.
    Caro-Diaz EJE; Urbano M; Buzard DJ; Jones RM
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5378-5383. PubMed ID: 27765505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How well do medicinal chemists learn from experience?
    Cheshire DR
    Drug Discov Today; 2011 Sep; 16(17-18):817-21. PubMed ID: 21704183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Retrosynthetic Reactions Using Self-Corrected Transformer Neural Networks.
    Zheng S; Rao J; Zhang Z; Xu J; Yang Y
    J Chem Inf Model; 2020 Jan; 60(1):47-55. PubMed ID: 31825611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.